相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B- cell Lymphoma
Sally E. Trabucco et al.
CLINICAL CANCER RESEARCH (2015)
Cell-Based Protein Stabilization Assays for the Detection of Interactions between Small-Molecule Inhibitors and BRD4
Jessica Schulze et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
Antje Dittmann et al.
ACS CHEMICAL BIOLOGY (2014)
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
Stuart W. J. Ember et al.
ACS CHEMICAL BIOLOGY (2014)
Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors
Marije Slingerland et al.
ANTI-CANCER DRUGS (2014)
The bromodomain: From epigenome reader to druggable target
Roberto Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
Aristeidis Chaidos et al.
BLOOD (2014)
Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
Jian Shi et al.
CANCER CELL (2014)
An epigenomic approach to therapy for tamoxifen-resistant breast cancer
Qin Feng et al.
CELL RESEARCH (2014)
Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis
Sutapa Ray et al.
CELLULAR SIGNALLING (2014)
Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors
Steven G. Smith et al.
CHEMISTRY & BIOLOGY (2014)
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
Mar Gacias et al.
CHEMISTRY & BIOLOGY (2014)
Naphthyridines as Novel BET Family Bromodomain Inhibitors
Olivier Mirguet et al.
CHEMMEDCHEM (2014)
Bromodomains and Their Pharmacological Inhibitors
Daniel Gallenkamp et al.
CHEMMEDCHEM (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
A mechanistic link between gene regulation and genome architecture in mammalian development
Giancarlo Bonora et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Chromatin: a capacitor of acetate for integrated regulation of gene expression and cell physiology
Siavash K. Kurdistani
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Role of Transcription Factor Acetylation in Diabetic Kidney Disease
Ruijie Liu et al.
DIABETES (2014)
BET bromodomain proteins are required for glioblastoma cell proliferation
Chiara Pastori et al.
EPIGENETICS (2014)
BET bromodomain inhibitors: a patent review
Jean-Marc Garnier et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Histone Cross-talk Connects Protein Phosphatase 1 α (PP1 α) and Histone Deacetylase (HDAC) Pathways to Regulate the Functional Transition of Bromodomain-containing 4 (BRD4) for Inducible Gene Expression
Xiangming Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Affinity Map of Bromodomain Protein 4 ( BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1
Marie Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells
Stuart J. Gallagher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
Oleg Fedorov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor
Romain Gosmini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Structure-based virtual screening of novel, high-affinity BRD4 inhibitors
Charuvaka Muvva et al.
MOLECULAR BIOSYSTEMS (2014)
BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen
Vaibhav Sahai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
M. A. Dawson et al.
LEUKEMIA (2014)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Genome-wide localization of small molecules
Lars Anders et al.
NATURE BIOTECHNOLOGY (2014)
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri et al.
NATURE CHEMICAL BIOLOGY (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
Friederike Itzen et al.
NUCLEIC ACIDS RESEARCH (2014)
MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma
A. R. Grayson et al.
ONCOGENE (2014)
Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
Z. Zou et al.
ONCOGENE (2014)
Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151
Stuart J. Gallagher et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells
Trent Fowler et al.
PLOS ONE (2014)
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
Joydeep Bhadury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
Michele Ceribelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes
Matthias G. J. Baud et al.
SCIENCE (2014)
Design and chemoproteomic functional characterization of a chemical probe targeted to bromodomains of BET family proteins
Jiang Wu et al.
MEDCHEMCOMM (2014)
Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
Ronen Marmorstein et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
M. Hussong et al.
CELL DEATH & DISEASE (2014)
Histone Deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1
Jeyran Shahbazi et al.
ONCOTARGET (2014)
Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription
Sankari Nagarajan et al.
CELL REPORTS (2014)
The anticancer effects of HDAC inhibitors require the immune system
Alison C. West et al.
ONCOIMMUNOLOGY (2014)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2013)
4-Acyl Pyrroles: Mimicking Acetylated Lysines in Histone Code Reading
Xavier Lucas et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Sarah Picaud et al.
CANCER RESEARCH (2013)
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Miguel F. Segura et al.
CANCER RESEARCH (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release
Wen Liu et al.
CELL (2013)
Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non-Small Cell Lung Cancer
Takeshi Shimamura et al.
CLINICAL CANCER RESEARCH (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers
Anouk Emadali et al.
EMBO MOLECULAR MEDICINE (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain
Lele Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
Lewis R. Vidler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains
Guangtao Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
Shwu-Yuan Wu et al.
MOLECULAR CELL (2013)
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
Scott R. Floyd et al.
NATURE (2013)
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
Anastasia Wyce et al.
PLOS ONE (2013)
RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
Kevin G. McLure et al.
PLOS ONE (2013)
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
Sarah Picaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
Duncan Hay et al.
MEDCHEMCOMM (2013)
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors
Victor S. Gehling et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
D. Da Costa et al.
BLOOD CANCER JOURNAL (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
Anastasia Wyce et al.
ONCOTARGET (2013)
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
Anton Henssen et al.
ONCOTARGET (2013)
Two faces of BRD4 Mitotic bookmark and transcriptional lynchpin
Ballachanda N. Devaiah et al.
TRANSCRIPTION-AUSTIN (2013)
Pathogenesis of NUT Midline Carcinoma
Christopher A. French
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
Panagis Filippakopoulos et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
Olivier Mirguet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
Jonathan Seal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes
Sebastian Schroeder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Bromodomain-containing Protein 4 (BRD4) Regulates RNA Polymerase II Serine 2 Phosphorylation in Human CD4+T Cells
Weishi Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Bromodomain Protein Brd4 Associated with Acetylated Chromatin Is Important for Maintenance of Higher-order Chromatin Structure
Ranran Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Down-regulation of NF-κB Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition
Guangtao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B
Pablo Garcia-Gutierrez et al.
JOURNAL OF CELL SCIENCE (2012)
Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
Paul V. Fish et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
William W. Lockwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem-and progenitor cells in acute myeloid leukemia (AML)
Harald Herrmann et al.
ONCOTARGET (2012)
A Combination of H2A.Z and H4 Acetylation Recruits Brd2 to Chromatin during Transcriptional Activation
Ryan Draker et al.
PLOS GENETICS (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors
Tamaki Ito et al.
CHEMISTRY & BIOLOGY (2011)
Selectivity of Kinase Inhibitor Fragments
Paul Bamborough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structural Basis and Specificity of Acetylated Transcription Factor GATA1 Recognition by BET Family Bromodomain Protein Brd3
Roland Gamsjaeger et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Shaila Rahman et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
Martin Philpott et al.
MOLECULAR BIOSYSTEMS (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
Janine M. Lamonica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain-Histone Interactions
Chun-Wa Chung et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
Nicolas Reynoird et al.
EMBO JOURNAL (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic Resolution
Friederike Vollmuth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regulation of Aurora B Expression by the Bromodomain Protein Brd4
Jianxin You et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase
Kazuki Mochizuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Brd4 recruits P-TER to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression
Zhiyuan Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription
Dwayne A. Bisgrovet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: Preservation of acetylated chromatin
A Nishiyama et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Selective recognition of acetylated histones by bromodomain proteins visualized in living cells
T Kanno et al.
MOLECULAR CELL (2004)
Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4
D Houzelstein et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
分享论文
